These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28256916)

  • 21. Female sterilization using chemical agents.
    Richart RM
    Res Front Fertil Regul; 1981 Dec; 1(5):1-12. PubMed ID: 12179630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemical Sterilization with an I.U.D. (Author's transl)].
    Laufe LE
    Contracept Fertil Sex (Paris); 1981 Jan; 9(1):17-20. PubMed ID: 12336729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and standardized incidence rates of preclinical cervical pathology among 1,061 women sterilized with transcervical quinacrine hydrochloride pellets.
    Dabancens A; Sokal DC; Pruyas M; Rivera M; Zipper J
    Fertil Steril; 1995 Aug; 64(2):444-6. PubMed ID: 7615128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women's Health Study.
    Huang Z; Gao Y; Wen W; Li H; Zheng W; Shu XO; Beeghly-Fadiel A
    Int J Cancer; 2015 Aug; 137(3):607-14. PubMed ID: 25556333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FHI quinacrine studies.
    Family Health International FHI
    Netw Res Triangle Park N C; 1995 Sep; 16(1):27. PubMed ID: 12290470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
    Hofmeyr GJ; Singata-Madliki M; Lawrie TA; Bergel E; Temmerman M
    Reprod Health; 2016 Apr; 13():42. PubMed ID: 27091008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraceptive effectiveness of two insertions of quinacrine: results from 10-year follow-up in Vietnam.
    Sokal DC; Hieu do T; Loan ND; Hubacher D; Nanda K; Weiner DH; Vach TH
    Contraception; 2008 Jul; 78(1):61-5. PubMed ID: 18555819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of quinacrine hydrochloride.
    Netw Int Fertil Res Program; 1979 Oct; ():5. PubMed ID: 12261374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinacrine sterilization (QS) in Syria: a preliminary report on 297 cases.
    Garabedian V
    Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 2():S133-5. PubMed ID: 14763201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New studies link IUDs, infertility; say copper devices safer.
    Contracept Technol Update; 1985 Jun; 6(6):81-3. PubMed ID: 12313655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical examination of the mode of action of quinacrine in the reproductive tract in a 2-year rat cancer bioassay and its implications for human clinical use.
    Haseman JK; Growe RG; Zeiger E; McConnell EE; Luster MI; Lippes J
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):371-8. PubMed ID: 25680263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large quinacrine study comes under fire from family planners.
    Contracept Technol Update; 1994 Apr; 15(4):45-7. PubMed ID: 12318750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Family planning in Viet Nam: a vigorous approach.
    Feuerstein MT
    World Health Stat Q; 1994; 47(1):36-9. PubMed ID: 8085369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary tubal infertility in relation to the use of an intrauterine device.
    Daling JR; Weiss NS; Metch BJ; Chow WH; Soderstrom RM; Moore DE; Spadoni LR; Stadel BV
    N Engl J Med; 1985 Apr; 312(15):937-41. PubMed ID: 3974683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of quinacrine sterilization (QS) and surgical sterilization (TL) in 600 women in Guizhou Province, China.
    Lu W; Zhu J; Zhong C; Zhao Y
    Int J Gynaecol Obstet; 2003 Dec; 83 Suppl 2():S51-S58. PubMed ID: 29645214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.